Pharmaceutical Market Europe • July/August 2021 • 26
RESEARCH NEWS
The UK government has outlined a new strategy for its life sciences sector, to ‘build on the successes of the COVID-19 response’.
The core mission of the new Life Sciences Vision’s aims to ensure scientific excellence in the UK over the next decade in a bid to enable the NHS to address the ‘most pressing’ health challenges.
Included in the strategy are seven healthcare missions focused on the early prevention, diagnosis, monitoring and treatment of disease, and the accelerated development and adoption of new drugs, diagnostics, medical technology and digital tools.
The strategy includes:
Clinical research activities in the UK are to benefit from £64m worth of dedicated funding as part of the government’s vision for ‘The Future of UK Clinical Research Delivery’.
The government has revealed the first phase of activity following the publication of the policy paper ‘The Future of UK Clinical Research Delivery’ in March 2021.
Over the coming months, this activity will include: